HWH International (NASDAQ:HWH) and Cencora (NYSE:COR) Head to Head Comparison

HWH International (NASDAQ:HWH) and Cencora (NYSE:COR) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Risk & Volatility

HWH International has a beta of -1.47, meaning that its share price is 247% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.

Valuation & Earnings

This table compares HWH International and Cencora’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HWH International	N/A	N/A	$550,000.00	N/A	N/A
Cencora	$638.56 million	69.50	$1.75 billion	$9.14	24.35

Cencora has higher revenue and earnings than HWH International.

Institutional & Insider Ownership

25.7% of HWH International shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 61.5% of HWH International shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares HWH International and Cencora’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
HWH International	N/A	-27.08%	-9.92%
Cencora	0.67%	268.67%	4.13%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for HWH International and Cencora, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HWH International	0	0	0	0	N/A
Cencora	0	3	6	0	2.67

Cencora has a consensus price target of $236.10, suggesting a potential upside of 6.10%. Given Cencora’s higher possible upside, analysts plainly believe Cencora is more favorable than HWH International.

Summary

Cencora beats HWH International on 9 of the 10 factors compared between the two stocks.

About HWH International

HWH International Inc. operates a marketplace to provide products and services for health, wealth, and happiness. The company operates through HWH Marketplace, Hapi Cafés, Hapi Travel, and Hapi Wealth Builder segments. The HWH Marketplace segment provides products manufactured by its affiliate companies at a discounted price to its members. The Hapi Cafés segment operates Hapi Cafe branded outlets in Asia, including Singapore, Republic of China (Taiwan), Hong Kong, the People's Republic of China, and South Korea. The Hapi Travel segment offers vacation packages, hotels, cruises, and other travel products for HWH members. The Hapi Wealth Builder segment focuses on exploring the options of providing services to its members through financial educational materials. The company is based in Bethesda, Maryland. HWH International Inc. operates as a subsidiary of Alset International Limited.

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.